血清尿酸水平与心血管疾病死亡率及慢性肾脏病风险 - Suppr

Suppr

超能文献

Serum uric acid level and risk of cardiovascular mortality and chronic kidney disease.

作者信息

Cacciapuoti Martina, Stefanelli Lucia Federica, Nalesso Federico, Calò Lorenzo A

机构信息

Nephrology, Dialysis and Transplantation Unit, Department of Medicine (DIMED), University of Padova, Italy.

出版信息

J Cardiovasc Med (Hagerstown). 2024 Nov 1;25(11):808-809. doi: 10.2459/JCM.0000000000001666. Epub 2024 Sep 27.

DOI:10.2459/JCM.0000000000001666

PMID:39347730

Abstract

摘要

相似文献

Serum uric acid level and risk of cardiovascular mortality and chronic kidney disease.

J Cardiovasc Med (Hagerstown). 2024 Nov 1;25(11):808-809. doi: 10.2459/JCM.0000000000001666. Epub 2024 Sep 27.

Associations of uric acid with the risk of cardiovascular disease and all-cause mortality among individuals with chronic kidney disease: the Kailuan Study.

Eur J Prev Cardiol. 2024 Dec 4;31(17):2058-2066. doi: 10.1093/eurjpc/zwae222.

Association of serum uric acid with all-cause and cardiovascular mortality in chronic kidney disease stages 3-5.

Nutr Metab Cardiovasc Dis. 2024 Jun;34(6):1518-1527. doi: 10.1016/j.numecd.2024.01.032. Epub 2024 Feb 6.

Serum Uric Acid and Mortality Form Cardiovascular Disease: EPOCH-JAPAN Study.

J Atheroscler Thromb. 2016;23(12):1365-1366. doi: 10.5551/jat.Er31591.

The role of uric acid in chronic kidney disease patients.

Nephrology (Carlton). 2017 Jun;22(6):441-448. doi: 10.1111/nep.12679.

Role of comorbidities in heart failure prognosis Part 2: Chronic kidney disease, elevated serum uric acid.

Eur J Prev Cardiol. 2020 Dec;27(2_suppl):35-45. doi: 10.1177/2047487320957793.

Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project.

High Blood Press Cardiovasc Prev. 2020 Apr;27(2):121-128. doi: 10.1007/s40292-020-00368-z. Epub 2020 Mar 10.

Effectiveness of febuxostat in patients with allopurinol-refractory hyperuricemic chronic kidney disease .

Int J Clin Pharmacol Ther. 2018 Jul;56(7):321-327. doi: 10.5414/CP202735.

Uric acid within the "normal" range predict 9-year cardiovascular mortality in older individuals. The InCHIANTI study.

Nutr Metab Cardiovasc Dis. 2019 Oct;29(10):1061-1067. doi: 10.1016/j.numecd.2019.06.018. Epub 2019 Jun 28.

Serum uric acid and risk of cardiovascular mortality: a systematic review and dose-response meta-analysis of cohort studies of over a million participants.

BMC Cardiovasc Disord. 2019 Oct 15;19(1):218. doi: 10.1186/s12872-019-1215-z.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Serum uric acid level and risk of cardiovascular mortality and chronic kidney disease.

作者信息

Cacciapuoti Martina, Stefanelli Lucia Federica, Nalesso Federico, Calò Lorenzo A

机构信息

Nephrology, Dialysis and Transplantation Unit, Department of Medicine (DIMED), University of Padova, Italy.

出版信息

J Cardiovasc Med (Hagerstown). 2024 Nov 1;25(11):808-809. doi: 10.2459/JCM.0000000000001666. Epub 2024 Sep 27.

DOI:10.2459/JCM.0000000000001666

PMID:39347730

Abstract

摘要

相似文献

Serum uric acid level and risk of cardiovascular mortality and chronic kidney disease.

J Cardiovasc Med (Hagerstown). 2024 Nov 1;25(11):808-809. doi: 10.2459/JCM.0000000000001666. Epub 2024 Sep 27.

Associations of uric acid with the risk of cardiovascular disease and all-cause mortality among individuals with chronic kidney disease: the Kailuan Study.

Eur J Prev Cardiol. 2024 Dec 4;31(17):2058-2066. doi: 10.1093/eurjpc/zwae222.

Association of serum uric acid with all-cause and cardiovascular mortality in chronic kidney disease stages 3-5.

Nutr Metab Cardiovasc Dis. 2024 Jun;34(6):1518-1527. doi: 10.1016/j.numecd.2024.01.032. Epub 2024 Feb 6.

Serum Uric Acid and Mortality Form Cardiovascular Disease: EPOCH-JAPAN Study.

J Atheroscler Thromb. 2016;23(12):1365-1366. doi: 10.5551/jat.Er31591.

The role of uric acid in chronic kidney disease patients.

Nephrology (Carlton). 2017 Jun;22(6):441-448. doi: 10.1111/nep.12679.

Role of comorbidities in heart failure prognosis Part 2: Chronic kidney disease, elevated serum uric acid.

Eur J Prev Cardiol. 2020 Dec;27(2_suppl):35-45. doi: 10.1177/2047487320957793.

Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project.

High Blood Press Cardiovasc Prev. 2020 Apr;27(2):121-128. doi: 10.1007/s40292-020-00368-z. Epub 2020 Mar 10.

Effectiveness of febuxostat in patients with allopurinol-refractory hyperuricemic chronic kidney disease .

Int J Clin Pharmacol Ther. 2018 Jul;56(7):321-327. doi: 10.5414/CP202735.

Uric acid within the "normal" range predict 9-year cardiovascular mortality in older individuals. The InCHIANTI study.

Nutr Metab Cardiovasc Dis. 2019 Oct;29(10):1061-1067. doi: 10.1016/j.numecd.2019.06.018. Epub 2019 Jun 28.

Serum uric acid and risk of cardiovascular mortality: a systematic review and dose-response meta-analysis of cohort studies of over a million participants.

BMC Cardiovasc Disord. 2019 Oct 15;19(1):218. doi: 10.1186/s12872-019-1215-z.